Open Access. Powered by Scholars. Published by Universities.®
Social and Behavioral Sciences Commons™
Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 4 of 4
Full-Text Articles in Social and Behavioral Sciences
What Is Overdiagnosis And Why Should We Take It Seriously In Cancer Screening?, Stacy M. Carter, Alexandra Barratt
What Is Overdiagnosis And Why Should We Take It Seriously In Cancer Screening?, Stacy M. Carter, Alexandra Barratt
Faculty of Social Sciences - Papers (Archive)
Overdiagnosis occurs in a population when conditions are diagnosed correctly but the diagnosis produces an unfavourable balance between benefits and harms. In cancer screening, overdiagnosed cancers are those that did not need to be found because they would not have produced symptoms or led to premature death. These overdiagnosed cancers can be distinguished from false positives, which occur when an initial screening test suggests that a person is at high risk but follow-up testing shows them to be at normal risk. The cancers most likely to be overdiagnosed through screening are those of the prostate, thyroid, breast and lung. Overdiagnosis …
Psa Testing For Men At Average Risk Of Prostate Cancer, Bruce Armstrong, Michael Barry, Mark Frydenberg, Robert A. Gardiner, Ian Haines, Stacy M. Carter
Psa Testing For Men At Average Risk Of Prostate Cancer, Bruce Armstrong, Michael Barry, Mark Frydenberg, Robert A. Gardiner, Ian Haines, Stacy M. Carter
Faculty of Social Sciences - Papers (Archive)
Prostate-specific antigen (PSA) testing of men at normal risk of prostate cancer is one of the most contested issues in cancer screening. There is no formal screening program, but testing is common - arguably a practice that ran ahead of the evidence. Public and professional communication about PSA screening has been highly varied and potentially confusing for practitioners and patients alike. There has been much research and policy activity relating to PSA testing in recent years. Landmark randomised controlled trials have been reported; authorities - including the 2013 Prostate Cancer World Congress, the Prostate Cancer Foundation of Australia, Cancer Council …
Patient, Oncologist And Gp Views About Cancer Follow-Up Care In General Practice, Heike Schutze, Melvin Chin, David Weller, Sue Suchy, Mark Fort Harris
Patient, Oncologist And Gp Views About Cancer Follow-Up Care In General Practice, Heike Schutze, Melvin Chin, David Weller, Sue Suchy, Mark Fort Harris
Faculty of Social Sciences - Papers (Archive)
Abstract presented at the 2nd International Conference on General Practice & Primary Care, 18-19 September 2017, Zurich, Switzerland
Patient, General Practitioner And Oncologist Views Regarding Long-Term Cancer Shared Care, Heike Schutze, Melvin Chin, David Weller, Mark Fort Harris
Patient, General Practitioner And Oncologist Views Regarding Long-Term Cancer Shared Care, Heike Schutze, Melvin Chin, David Weller, Mark Fort Harris
Faculty of Social Sciences - Papers (Archive)
Background The rising incidence of cancer and increasing number of cancer survivors place competing demands on specialist oncology clinics. This has led to a need to consider collaborative care between primary and secondary care for the long-term post-treatment care of cancer survivors. Objective To explore the views of breast and colorectal cancer survivors, their oncologist and GP about GPs taking a more active role in long-term cancer follow-up care. Methods Semi-structured interviews using a thematic analysis framework. Respondents were asked their views on the specialist hospital-based model for cancer follow-up care and their views on their GP taking a greater …